{
  "meta": {
    "disclaimer": "Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service.",
    "terms": "https://open.fda.gov/terms/",
    "license": "https://open.fda.gov/license/",
    "last_updated": "2026-09-29",
    "results": {
      "skip": 0,
      "limit": 1,
      "total": 1
    }
  },
  "results": [
    {
      "product_ndc": "10956-703",
      "generic_name": "PHENAZOPYRIDINE HYDROCHLORIDE",
      "labeler_name": "Reese Pharmaceutical Co",
      "brand_name": "Vexia Maximum Strength Urinary Pain Relief",
      "active_ingredients": [
        {
          "name": "PHENAZOPYRIDINE HYDROCHLORIDE",
          "strength": "99.5 mg/1"
        }
      ],
      "finished": true,
      "packaging": [
        {
          "package_ndc": "10956-703-24",
          "description": "1 BLISTER PACK in 1 CARTON (10956-703-24)  / 24 TABLET in 1 BLISTER PACK",
          "marketing_start_date": "20230524",
          "sample": false
        }
      ],
      "listing_expiration_date": "20261231",
      "openfda": {
        "manufacturer_name": [
          "Reese Pharmaceutical Co"
        ],
        "rxcui": [
          "1094147"
        ],
        "spl_set_id": [
          "5fbc47d2-cecd-4187-9bcc-51b1d0b7695d"
        ],
        "is_original_packager": [
          true
        ],
        "unii": [
          "0EWG668W17"
        ]
      },
      "marketing_category": "UNAPPROVED DRUG OTHER",
      "dosage_form": "TABLET",
      "spl_id": "117fb757-2c46-4923-855d-4438e1976e49",
      "product_type": "HUMAN OTC DRUG",
      "route": [
        "ORAL"
      ],
      "marketing_start_date": "20230524",
      "product_id": "10956-703_117fb757-2c46-4923-855d-4438e1976e49",
      "brand_name_base": "Vexia Maximum Strength Urinary Pain Relief"
    }
  ]
}